BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38471504)

  • 1. An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI.
    Garcia-Ruiz A; Pons-Escoda A; Grussu F; Naval-Baudin P; Monreal-Aguero C; Hermann G; Karunamuni R; Ligero M; Lopez-Rueda A; Oleaga L; Berbís MÁ; Cabrera-Zubizarreta A; Martin-Noguerol T; Luna A; Seibert TM; Majos C; Perez-Lopez R
    Cell Rep Med; 2024 Mar; 5(3):101464. PubMed ID: 38471504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.
    Choi KS; Choi SH; Jeong B
    Neuro Oncol; 2019 Sep; 21(9):1197-1209. PubMed ID: 31127834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted, contrast-enhanced MRI in the preoperative diagnosis of cerebral tumours.
    Chakravorty A; Steel T; Chaganti J
    Neuroradiol J; 2015 Dec; 28(6):574-83. PubMed ID: 26475485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated analysis combining [
    Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study.
    Ammari S; Bône A; Balleyguier C; Moulton E; Chouzenoux É; Volk A; Menu Y; Bidault F; Nicolas F; Robert P; Rohé MM; Lassau N
    Invest Radiol; 2022 Feb; 57(2):99-107. PubMed ID: 34324463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Deep Learning-Based Model to Distinguish Glioblastoma from Solitary Brain Metastasis Using Conventional MR Images.
    Shin I; Kim H; Ahn SS; Sohn B; Bae S; Park JE; Kim HS; Lee SK
    AJNR Am J Neuroradiol; 2021 May; 42(5):838-844. PubMed ID: 33737268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion Maps Acquired From Dynamic Angiography MRI Using Deep Learning Approaches.
    Asaduddin M; Roh HG; Kim HJ; Kim EY; Park SH
    J Magn Reson Imaging; 2023 Feb; 57(2):456-469. PubMed ID: 35726646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning for semi-automated classification of glioblastoma, brain metastasis and central nervous system lymphoma using magnetic resonance advanced imaging.
    Swinburne NC; Schefflein J; Sakai Y; Oermann EK; Titano JJ; Chen I; Tadayon S; Aggarwal A; Doshi A; Nael K
    Ann Transl Med; 2019 Jun; 7(11):232. PubMed ID: 31317002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
    J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
    Jayachandran Preetha C; Meredig H; Brugnara G; Mahmutoglu MA; Foltyn M; Isensee F; Kessler T; Pflüger I; Schell M; Neuberger U; Petersen J; Wick A; Heiland S; Debus J; Platten M; Idbaih A; Brandes AA; Winkler F; van den Bent MJ; Nabors B; Stupp R; Maier-Hein KH; Gorlia T; Tonn JC; Weller M; Wick W; Bendszus M; Vollmuth P
    Lancet Digit Health; 2021 Dec; 3(12):e784-e794. PubMed ID: 34688602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning quantification of vascular pharmacokinetic parameters in mouse brain tumor models.
    Arledge CA; Sankepalle DM; Crowe WN; Liu Y; Wang L; Zhao D
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):99. PubMed ID: 35345331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Evaluation of a Multiparametric Deep Learning Model for Glioblastoma Segmentation Using Heterogeneous Magnetic Resonance Imaging Data From Clinical Routine.
    Perkuhn M; Stavrinou P; Thiele F; Shakirin G; Mohan M; Garmpis D; Kabbasch C; Borggrefe J
    Invest Radiol; 2018 Nov; 53(11):647-654. PubMed ID: 29863600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis.
    Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Grussu F; Fernandez JJS; Simo AC; Sarro NV; Fernandez-Coello A; Bruna J; Cos M; Perez-Lopez R; Majos C
    Eur Radiol; 2022 Jun; 32(6):3705-3715. PubMed ID: 35103827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Deep Learning Model for Brain Tumor Diagnosis and Classification Using Magnetic Resonance Imaging.
    Gao P; Shan W; Guo Y; Wang Y; Sun R; Cai J; Li H; Chan WS; Liu P; Yi L; Zhang S; Li W; Jiang T; He K; Wu Z
    JAMA Netw Open; 2022 Aug; 5(8):e2225608. PubMed ID: 35939301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic property incorporated brain tumor segmentation by deep learning and density-based analysis of dynamic susceptibility contrast-enhanced magnetic resonance imaging (MRI).
    Tang L; Wu T; Hu R; Gu Q; Yang X; Mao H
    Quant Imaging Med Surg; 2024 Apr; 14(4):2774-2787. PubMed ID: 38617153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
    Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
    She D; Xing Z; Cao D
    J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wavelet-based reconstruction of dynamic susceptibility MR-perfusion: a new method to visualize hypervascular brain tumors.
    Huber T; Rotkopf L; Wiestler B; Kunz WG; Bette S; Gempt J; Preibisch C; Ricke J; Zimmer C; Kirschke JS; Sommer WH; Thierfelder KM
    Eur Radiol; 2019 May; 29(5):2669-2676. PubMed ID: 30552476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.